Filippo Acconcia

Filippo Acconcia

Oct 14, 2017

Group 6 Copy 106
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can We Defeat EBOLA with an Experimental CANCER Drug?

The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and...

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes. Many...

Campaign Ended